Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Oxford Nanopore's Applied Markets Push Sparks Renewed Investor Optimism

Oxford Nanopore Technologies PLC shares rose 2.15% today to around 175.90p, as investors respond positively to the DNA and RNA sequencing specialist's progress in expanding beyond its core research customer base into higher-value clinical and biopharma applications.

Divya Sood | 22 September 2026

Polar Capital Global Healthcare Trust Bounces Back as Sector Sentiment Improves

Polar Capital Global Healthcare Trust plc shares rose 1.14% today to around 444.00p, as global healthcare equities staged a partial recovery after a period of relative underperformance against the broader market.

Divya Sood | 22 September 2026

Syncona Edges Higher as Life Science Portfolio Nears Key Inflection Points

Syncona Limited shares rose 1.36% today to around 119.00p, as investors positioned ahead of a series of expected clinical and corporate catalysts across the life scienceInvestmenttrust's portfolio of gene and cell therapy companies.

Divya Sood | 22 September 2026

How Could Cell and Gene Therapy Demand Shape FTSE 250 Stock Oxford BioMedica (LSE:OXB)?

The full-year 2025 results, for the year ended 31 December 2025 and reported on 26 March 2026, marked an important milestone. TotalRevenuerose 33% on a constant-currency basis to £170.9m, and the company reported operating EBITDA of £8.1m, against a £15.3m loss the prior year, …

Ankur Sharma | 22 September 2026

What Could Injectable and Generic Drug Demand Mean for FTSE 100 Stock Hikma Pharmaceuticals (LSE:HIK)?

The half-year 2026 results, for the six months ended 30 June 2026, showed steady progress. CoreRevenuerose 4% to $1,728m, core operating profit rose 9% to $405m at aMarginof 23.4%, up 90 basis points, and coreBasic Earnings Per Sharerose 5% to 128 cents, according to …

Ankur Sharma | 22 September 2026

LSE:AGY Stock in Focus After 8.65% Fall: Can Allergy Therapeutics Deliver Double-Digit Growth in FY27?

Allergy Therapeutics became a notable healthcare-sector mover on 21 September 2026, withLSE:AGY declining 8.65% to 4.75p.

Ankur Sharma | 22 September 2026

Craneware Shares Plunge 26%: Cyber Incident and Revenue Reset Put CRW Stock in Focus

Craneware plc became one of the most closely watched UK healthcare technology stocks on 21 September afterLSE:CRW fell 25.78% to 996p.

Ankur Sharma | 22 September 2026

Covalon Technologies TSXV:COV Gains 5.95%: Is Strong MedTech Growth Driving Investor Attention?

Covalon Technologies Ltd. (TSXV:COV) rose5.95% on September 21, 2026, extending investor attention around the company's improving financial performance and commercial expansion in medical technology.

Ankur Sharma | 21 September 2026

DRI Healthcare Gains 4.96%: What Is Driving Investor Attention Around Its New Parkinson’s Drug Royalty?

DRI Healthcare stock rose4.96% on September 21, 2026, with the latest move coinciding directly with a significant new royaltyAcquisitionannouncement.

Ankur Sharma | 21 September 2026

How Could NHS Waiting Lists Shape FTSE AIM All-Share Stock One Health Group (LSE:OHGR)?

The full-year results for the year to 31 March 2026 continued a run of expansion.Revenuerose 11% to £31.6m, adjusted EBITDA increased 28% to £2.6m, and the company ended the year with cash of £11.1m, proposing aDividendof 6.3p, according to its reporting. This marked a …

Ankur Sharma | 21 September 2026
Support

Hi! How can we help you today?

Loading…